JP2024510436A5 - - Google Patents
Info
- Publication number
- JP2024510436A5 JP2024510436A5 JP2023554337A JP2023554337A JP2024510436A5 JP 2024510436 A5 JP2024510436 A5 JP 2024510436A5 JP 2023554337 A JP2023554337 A JP 2023554337A JP 2023554337 A JP2023554337 A JP 2023554337A JP 2024510436 A5 JP2024510436 A5 JP 2024510436A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163162501P | 2021-03-17 | 2021-03-17 | |
| US63/162,501 | 2021-03-17 | ||
| US202163284592P | 2021-11-30 | 2021-11-30 | |
| US63/284,592 | 2021-11-30 | ||
| PCT/US2022/020716 WO2022197901A1 (en) | 2021-03-17 | 2022-03-17 | A 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid for the treatment of major depressive disorder |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024510436A JP2024510436A (ja) | 2024-03-07 |
| JP2024510436A5 true JP2024510436A5 (https=) | 2025-03-25 |
| JPWO2022197901A5 JPWO2022197901A5 (https=) | 2025-03-25 |
Family
ID=81327141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023554337A Pending JP2024510436A (ja) | 2021-03-17 | 2022-03-17 | 大うつ病性障害の処置のための１９－ノルｃ３，３－２置換ｃ２１－ｎ－ピラゾリルステロイド |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240245711A1 (https=) |
| EP (1) | EP4308162A1 (https=) |
| JP (1) | JP2024510436A (https=) |
| KR (1) | KR20230158033A (https=) |
| AU (1) | AU2022238365A1 (https=) |
| BR (1) | BR112023018607A2 (https=) |
| CA (1) | CA3213744A1 (https=) |
| IL (1) | IL305858A (https=) |
| MX (1) | MX2023010728A (https=) |
| TW (1) | TW202300156A (https=) |
| WO (1) | WO2022197901A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2015002252A (es) | 2012-08-21 | 2015-07-21 | Sage Therapeutics Inc | Metodos para tratar epilepsia o estado de epilepsia. |
| JP6470258B2 (ja) | 2013-04-17 | 2019-02-13 | セージ セラピューティクス， インコーポレイテッド | １９−ノルｃ３，３−ジ置換ｃ２１−ｎ−ピラゾリルステロイドおよびその使用方法 |
| WO2015195962A1 (en) | 2014-06-18 | 2015-12-23 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
| WO2016082789A1 (en) | 2014-11-27 | 2016-06-02 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| TWI904593B (zh) | 2016-08-23 | 2025-11-11 | 美商賽吉醫療公司 | 結晶19-去甲c3,3-二取代之c21-n-吡唑類固醇 |
| EP3720867A1 (en) | 2017-12-08 | 2020-10-14 | Sage Therapeutics, Inc. | Deuterated 21 -[4-cyano-pyrazol-1 -yl]-19-nor-pregan-3. alpha-ol-20-one derivatives for treating cns disorders |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6470258B2 (ja) | 2013-04-17 | 2019-02-13 | セージ セラピューティクス， インコーポレイテッド | １９−ノルｃ３，３−ジ置換ｃ２１−ｎ−ピラゾリルステロイドおよびその使用方法 |
| TWI904593B (zh) | 2016-08-23 | 2025-11-11 | 美商賽吉醫療公司 | 結晶19-去甲c3,3-二取代之c21-n-吡唑類固醇 |
| EP3612186A1 (en) * | 2017-04-18 | 2020-02-26 | Marinus Pharmaceuticals, Inc. | Sustained release injectable neurosteroid formulations |
| EP3678670A1 (en) * | 2017-09-07 | 2020-07-15 | Sage Therapeutics, Inc. | Neuroactive steroids and their methods of use |
| CA3103421A1 (en) * | 2018-06-12 | 2019-12-19 | Sage Therapeutics, Inc. | A 19-nor c3,3-disubstituted c21 -n-pyrazolyl steroid and methods of use thereof |
| US20230285417A1 (en) | 2020-07-20 | 2023-09-14 | Sage Therapeutics, Inc. | Formulations of 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereof |
| US20230372364A1 (en) * | 2020-10-01 | 2023-11-23 | Jeremy Hill | Method of treating gaba mediated disorders |
-
2022
- 2022-03-17 AU AU2022238365A patent/AU2022238365A1/en active Pending
- 2022-03-17 WO PCT/US2022/020716 patent/WO2022197901A1/en not_active Ceased
- 2022-03-17 EP EP22715444.0A patent/EP4308162A1/en active Pending
- 2022-03-17 IL IL305858A patent/IL305858A/en unknown
- 2022-03-17 US US18/550,724 patent/US20240245711A1/en active Pending
- 2022-03-17 MX MX2023010728A patent/MX2023010728A/es unknown
- 2022-03-17 JP JP2023554337A patent/JP2024510436A/ja active Pending
- 2022-03-17 KR KR1020237034937A patent/KR20230158033A/ko active Pending
- 2022-03-17 CA CA3213744A patent/CA3213744A1/en active Pending
- 2022-03-17 BR BR112023018607A patent/BR112023018607A2/pt unknown
- 2022-03-17 TW TW111109951A patent/TW202300156A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024510436A5 (https=) | ||
| BR102022025291A2 (https=) | ||
| CL2026000082A1 (es) | Método y disposición para predecir cod en un proceso de tratamiento de aguas residuales. | |
| BR102023007252A2 (https=) | ||
| BR102023005164A2 (https=) | ||
| BR102023001877A2 (https=) | ||
| BR102023000289A2 (https=) | ||
| BR102022026909A2 (https=) | ||
| BR102022023461A2 (https=) | ||
| BY13168U (https=) | ||
| CN307048531S (https=) | ||
| CN307044823S (https=) | ||
| CN307044675S (https=) | ||
| BY13161U (https=) | ||
| BY23967C1 (https=) | ||
| BY23963C1 (https=) | ||
| BY13176U (https=) | ||
| BY13175U (https=) | ||
| BY13174U (https=) | ||
| BY13172U (https=) | ||
| BY13170U (https=) | ||
| CN307046346S (https=) | ||
| BY13169U (https=) | ||
| BY13159U (https=) | ||
| BY13167U (https=) |